Is CBL Really a Melanoma Driver? Variant Interpretation Under Scrutiny in Stage II Disease
Pathologists challenge the designation of CBL as a new driver gene in stage II melanoma, arguing that variant reporting gaps ...
Pathologists challenge the designation of CBL as a new driver gene in stage II melanoma, arguing that variant reporting gaps ...
A new correspondence in the British Journal of Cancer cautions that unadjusted statistical significance and sub-stage confounding must be resolved ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine